SHERPA

Welcome to the Brand page for “SHERPA”, which is offered here for Analysis of cells, antigens, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping medical diagnosis and treatment and drug design and development; preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, antigen characteristics and immunological response, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment and drug design and development;design of algorithms and models for use in scientific and medical research, all in the field of bioinformatics, genomics and gene expression research and development; platform as a service (paas) featuring computer software platforms for using algorithms to analyze cells, antigens, tissues, gene expressions, gene sequences, genome annotation, antigen characteristics and immunological responses, transcriptome characterization, and genome mapping for medical diagnosis and treatment; platform as a service (paas) featuring computer software platforms for using algorithms to predict antigen characteristics and immunological responses; providing data analysis and interpretation regarding antigen characteristics and immunological responses, and research and design relating thereto;.

Its status is currently believed to be active. Its class is unavailable. “SHERPA” is believed to be currently owned by “Personalis, Inc.”